XLO (STOCKS)

    Xilio Therapeutics, Inc. Common Stock

    $9.020000
    +0.120000 (+1.35%)
    Prev close: $8.900000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Pharmaceuticals: Major
    CEO
    René Russo
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $59.35M
    Employees
    73
    P/E (TTM)
    -5.28
    P/B (TTM)
    0.81
    Dividend Yield
    —
    Technical Indicators
    SMA 10
    —
    SMA 20
    —
    SMA 50
    —
    EMA 9
    —
    EMA 21
    —
    RSI
    —
    MACD State
    —

    Analyst Recommendations
    2
    Strong Buy
    2
    Buy
    1
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Jun 2026 (Q2)
    $-0.33 $-0.60 +0.2659 +44.62%
    Mar 2026 (Q1)
    $-0.58 $-0.67 +0.0866 +12.99%
    Dec 2025 (Q4)
    $0.81 $-1.70 +2.5068 +147.74%
    Sep 2025 (Q3)
    $-0.08 $-0.42 +0.3402 +80.20%